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INTRODUCTION
Follicular helper T cells (T FH
are a specialized T cell subset that provides help to B cells for antibody production . The main effector site of T FH is the germinal center (GC) within the secondary lymphoid organs. The interaction between T FH and B cells leads to GC formation and the development of high affinity antibodies that are central for T cell-dependent antibody response, and therefore T FH are considered critical for infection-or vaccine-induced protective immunity (Crotty, 2014) , (Slight et al., 2013) . Most of the evidence supporting a critical role of T FH are derived from studies in mice, whereas direct evidence from humans on T FH 's role in vaccine-induced immunity is lacking due to the difficulty to obtain human secondary lymphoid tissue (Schmitt and Ueno) . However, recent studies demonstrated that the response of "T FH -like" cells in peripheral blood following parenteral influenza vaccination correlated well with the antihemagglutinin (HA) antibody response, which provide supporting evidence for the importance of T FH in vaccine-induced response in humans (Bentebibel et al., 2013) , (Spensieri et al., 2013) .
Recently, identification of novel agent/adjuvants that promote T FH number or function thus to enhance antibody response has become an attractive vaccination strategy (Fazilleau et al., 2009; Spensieri et al., 2013) .
There is increasing interest recently in developing mucosal vaccines such as intranasally administered vaccines against respiratory tract infections(Lycke, 2012). Nasopharynx-associated lymphoid tissues (NALT) comprising of adenoids and tonsils are secondary lymphoid organs known to be important induction sites for natural immunity against respiratory tract pathogens including influenza virus (Kiyono et al., 2004) . Also, they are a major induction site for immunity induced by intranasal vaccines, such as live-attenuated influenza vaccines (LAIV). As immune tolerance is a major feature of the mucosal immune system, it is generally considered that mucosal vaccination needs either a live-attenuated vaccine or an inactivated virus or subunit vaccine antigen together with an adjuvant. LAIV has been demonstrated to be an effective M A N U S C R I P T
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However, LAIV is not licensed for young children < 2 years because of concerns over increased risk of wheezing (Belshe et al., 2007) . There is a need for an alternative intranasal vaccine for this age group and that may include inactivated influenza virus antigens with an effective mucosal adjuvant.
Dendritic cells (DC) were shown to be important to initiate T FH cell development (Goenka et al., 2011) . Within mucosal lymphoid tissue including human tonsils, plasmacytoid DC (pDC) has been shown to be an important DC population (Polak et al., 2008; Rescigno, 2013) . In humans, pDC uniquely express both TLR-7 and TLR-9 which are not found on myeloid DC (Hornung et al., 2002) . CpG-DNA, a TLR-9 ligand, has been shown to possess adjuvant activity capable of enhancing antibody responses, including that intranasal administration of CpG-DNA enhanced antibody response to co-administered influenza vaccines in animal models (Klinman, 2006; McCluskie and Davis, 1999; Weeratna et al., 2000) , (Moldoveanu et al., 1998) . Recent studies in mice suggest CpG-DNA may potentiate T FH response by monocyte-derived DC to modulate antibody production (Chakarov and Fazilleau, 2014) . However, it is not known whether CpG-DNA promotes T FH in humans and whether pDC contribute to promoting T FH and by which enhances vaccine antigen-induced response.
A central marker of T FH cells is CXC-chemokine receptor 5 (CXCR5), which is important for T FH positioning in GC (Schaerli et al., 2000) . T FH are typically identified by co-expression of CXCR5
together with other markers including ICOS, PD-1, BCL-6 (Breitfeld et al., 2000; Kim et al., 2001 ) (Choi et al., 2011; Fazilleau et al., 2009; Kerfoot et al., 2011; King, 2009; Laurent et al., 2010) . A number of cytokines, particularly IL-21, are produced by T FH , and are considered to have a major role in T FH differentiation and function on B cell antibody response (King, 2009) .
In this study, we examined the role of T FH in influenza vaccines-or antigen-induced anti-HA response in human NALT immune cells, and studied whether a candidate adjuvant CpG-DNA M A N U S C R I P T
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3. Cell separation, culture, and stimulation. Mononuclear cells (MNC) from adenotonsillar tissue were isolated using Ficoll density centrifugation (Zhang et al., 2006) (Zhang et al., 2011) and the number of MNC isolated from each patient ranged from 5.0x10 7 -1.0x10 9 . In some experiments, tonsillar MNC were depleted of effector and memory (CD45RO + ) cells using CD45RO microbeads and magnetic cell sorting (Miltenyi) as described previously (Gray et al., 2014; Zhang et al., 2007) . The depletion of CD45RO + cells from tonsillar MNC removed T FH cells (>98%). Unfractionated MNC or CD45RO+cell-depleted MNC were cultured (4x10 6 /ml) in 96-well flat-bottom culture plates in RPMI-1640 medium with HEPES supplemented with 10% fetal bovine serum (FBS), 1% L-glutamine, streptomycin (50µg/ml) and penicillin (50U/ml) (Sigma), in the presence of CpG-DNA, inactivated sH1N1 antigen, or LAIV. Cell culture supernatants were collected and stored at -80°C until analysis for antibody or cytokine production by ELISA.
The effect of IL21 on T FH and T FH -mediated help for antibody production was examined using recombinant human IL21R-Fc chimera (R&D systems) (IL21-Fc). IL21-Fc (or isotype control) (10µg/ml) was incubated with tonsillar MNC or with T FH -B cell co-culture for 1 hour, before the addition of CpG-DNA (0.1µg/ml) and/or sH1N1 antigen (1µg/ml). The cells were then cultured for up to 10 days for analysis of T FH numbers and of antibody production.
Measurement of HA-Specific antibodies.
Production of HA-specific IgG, IgM and IgA antibodies to sH1N1 virus in cell culture supernatants was measured as previously described (Ahmed et al., 2015) , (Mahallawi et al., 2013) . In brief, ELISA plates were coated with recombinant HA overnight. Following blocking, cell culture supernatants were added and incubated for 2 hours. Alkaline phosphatase-conjugated anti-human IgG, IgM or IgA antibody was then added and incubated. Following the addition of pNPP substrate, color development was read at OD405nm and data were analysed using DeltaSoft software.
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7 | P a g e 2.5. Analysis of T FH, cell proliferation and intracellular cytokine expression. For T FH identification, tonsillar MNC were stained with anti-human CD3, CD4, CXCR5, ICOS, CCR7, and Bcl-6 antibodies followed by flow cytometry (Rasheed et al., 2006) . Cell proliferation was examined by CFSE staining of tonsillar MNC (Molecular Probes, UK), followed by cell stimulation for 5 days and by flow cytometry. Intracellular cytokine staining was performed following overnight cell stimulation as described previously (Zhang et al., 2011) . Intracellular staining for Bcl-6 and TLR9 was performed following manufacturer's instructions with antihuman Bcl-6 and TLR-9 antibodies (eBioscience). Flow cytometry was performed using FACS Calibure (BD Biosciences) and data analyzed using WinMDI software (Scripps Institute).
Purification of T FH , B cells and pDC. T FH , B cells and pDC were purified from tonsillar
MNC using magnetic cell sorting (EasySep™, Stemcell). Briefly, tonsillar B cells were purified by negative selection using B cell purification kit which yielded B cell purity >99%. For T FH purification, CD4 + T cells were first isolated by negative selection using CD4 + T cell kit, followed by positive selection of CXCR5 high (T FH ) using biotin anti-human CXCR5 antibody. The amount of anti-CXCR5 antibody was optimised to ensure only CXCR5 high -expressing cells were selected (purity>95%). CD4 + CXCR5 -(non-T FH ) cells were purified by negative selection from CD4 + T cells using an optimised amount of anti-CXCR5 antibody to ensure only CXCR5 -cells were obtained (purity >99%). Tonsillar pDC were purified using negative selection with human plasmacytoid DC kit (Stemcell) which yielded a pDC purity >96%. From a total of 5.0x10 7 MNC, the numbers of isolated T FH , B cell and pDC were ranged 2.0-4.0x10 6 , 1.0-1.5x10 7 , and 1.0-2.0x10 5 respectively.
T FH -B cell co-culture.
The ability of tonsillar T FH to help B cell antibody production was examined by an autologous B cell-T FH co-culture. Purified B cells were co-cultured (1:1 ratio) with either purified T FH or non-T FH cells at 5x10 5 cells/ml in a 96-well round bottom plate, in the presence of CpG-DNA and/or sH1N1 virus antigen. The cells were cultured for 10 days and cell M A N U S C R I P T
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T FH mediate LAIV-and inactivated antigen-induced antibody production.
We sought to determine whether T FH play a role in the antibody response induced by current influenza vaccines in an immune induction site eg. NALT. Stimulation by LAIV induced a marked increase in T FH number in tonsillar MNC, which was correlated with a marked production of anti-sH1N1 HA antibodies including IgG, IgM and IgA (Figure 3a) . Stimulation by the inactivated sH1N1 antigen induced a modest increase in T FH number which correlated with a modest production of IgG and with little production of IgM and IgA anti-HA antibodies (3b). 
CpG-DNA promotes T FH and enhances anti-HA antibody production.
To determine whether CpG-DNA could promote T FH thereby enhancing the B cell anti-HA antibody response, tonsillar MNC were stimulated with CpG-DNA with/without the inactivated sH1N1 virus antigen. As shown in figure 4a, CpG-DNA elicited a dose-dependent increase in T FH frequency in tonsillar MNC. CpG-DNA at a low dose at 0.1 µg/ml, together with the sH1N1 antigen, elicited a marked increase in T FH number (4b) which correlated with a T FH cell proliferative response (4c) in tonsillar MNC, and significantly higher than that elicited by the sH1N1 antigen alone (4b+c, p<0.01). In the meantime, CpG-DNA together with sH1N1 antigen elicited a marked increase in IgG, IgM, and IgA anti-HA antibody production, much higher than that elicited by sH1N1 antigen alone (4d).
CpG-DNA-mediated enhancement of anti-HA antibody production involves T FH and IL21.
To further determine whether T FH contribute to CpG-DNA mediated enhancement of antibody production, purified B cells were co-cultured with T FH or non-T FH cells in the presence of CpG-
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IL21 concentrations in tonsillar MNC and the T FH -B cell co-culture were analyzed. As shown in Figure 5b , CpG-DNA stimulation induced an increase in IL21 concentration in the cultured MNC. In the T FH -B cell co-culture, following stimulation, significant production of IL-21 was only seen in the presence, but not in the absence of T FH (5c). Further, IL21 receptor blocking by the use of IL21R-Fc chimera abrogated the increase in T FH elicited by CpG-DNA and sH1N1
antigen stimulation (5d). In the meantime, the IL-21 receptor blocking reduced the production of anti-HA IgA and IgM antibodies in tonsillar MNC (5e).
Induction of T FH differentiation by CpG-DNA with influenza antigen.
To determine whether CpG-DNA promotes induction of T FH from naïve T cells, tonsillar MNC depleted of CD45RO + cells (removed effector and memory T cells including T FH ) were stimulated
with CpG-DNA with the inactivated sH1N1 antigen for 7 days. As shown in Figure 6a , the stimulation induced a marked increase in the number of T FH (CD4 + CXCR5 high ) which was significantly higher than the sH1N1 antigen stimulation alone (p<0.01).
Effect of pDC on T FH-mediated antibody response.
When we analyzed TLR9 expression using flow cytometry, no significant expression was shown by purified T FH or non-T FH CD4+T cells (data not shown). By contrast, a proportion of B cells and most pDC were shown to express TLR9 (6b). Since there was a prominent number of pDC in tonsillar tissue which expressed a high level of TLR9, we examined the effect of pDC on CpG-DNA and T FH mediated antibody response. Purified pDC were added to the T FH -B cell co-culture, and co-incubated with CpG-DNA with the inactivated sH1N1 antigen. As shown in Figure 6c , the addition of pDC further enhanced the anti-HA IgM and IgA antibody production in the T FH -B cell co-culture.
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NALT is a unique inductive site for B-cell response and plasma cell generation in the upper respiratory tract, which makes the intranasal route of vaccination an attractive strategy against airway infection such as influenza (Brandtzaeg, 2011) . As T FH are critical for T cell-dependent antibody response, promoting T FH in NALT may be an effective strategy for intranasal vaccination.
In this study, we first studied the frequency of T FH in NALT tissue of children and adults, and
showed that NALT of children aged 1.5-10 years contained abundant T FH ( Figure 1+2 ). The finding that children as young as 1.5 years (Bentebibel et al., 2013) .
We then studied the function of T FH in human NALT, and more specifically on whether the T FH play an important role in influenza antigen-induced antibody response. We showed that stimulation by LAIV elicited a marked increase in T FH number in tonsillar MNC that correlated with a strong production of anti-sH1N1 HA IgG, IgM and IgA antibodies (Figure 3a) . By comparison, stimulation by an inactivated sH1N1 antigen elicited a small increase in T FH that correlated with a modest anti-HA antibody production which was predominantly IgG (Figure 3b ).
Further, we demonstrated that the antibody responses induced by both LAIV and the inactivated sH1N1 antigen were dependent on the presence of T FH in the co-culture with B cells (Figure   3c+d ). These results support the hypothesis that T FH may be critical in influenza vaccine-induced anti-HA response in humans (Bentebibel et al., 2013; Spensieri et al., 2013) .
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Information on antibody responses to influenza antigens in human NALT is limited. Our results on antibody responses in the NALT tissue induced by LAIV and the inactivated sH1N1 antigen are in general consistent with previous findings that intranasally administered LAIV induced prominent antibody responses including IgA and IgG in nasal lavage mucosal samples (Moldoveanu et al., 1995) , and the inactivated antigen elicits primarily an IgG-predominant memory response (Bentebibel et al., 2013) . Given that many subjects would have been exposed previously to infection of various strains of influenza viruses, it is plausible that these previous contact induced memory and would to some degree have impact on the antibody response tested in this study. The relative predominance of IgG antibody production is concordant with the general predominance of IgG immunocytes in adenotonsillar tissue (Boyaka et al., 2000) . A liveattenuated vaccine, which resembles more closely to a natural infection, is generally used without an adjuvant and activates a stronger innate and broader immune response than an inactivated vaccine (Siegrist, 2013; Sridhar et al., 2015) . For an inactivated virus antigen, an adjuvant is usually needed and some adjuvants have been shown to greatly augment the immune response induced by inactivated influenza vaccines (Nicholson et al., 2001 ).
We further studied whether an adjuvant could be used to promote T FH and by which enhances the antibody response induced by the inactivated influenza antigen. CpG-DNA, as a TLR9 ligand, has been studied as a candidate adjuvant. We found that CpG-DNA stimulation of tonsillar MNC promoted the T FH number in a dose-dependent manner. Also, a low dose of CpG-DNA (0.1ug/ml) with the inactivated sH1N1 antigen markedly increased T FH number, and correlated with an and B cell responses (Chakarov and Fazilleau, 2014; Mastelic et al., 2012; Rookhuizen and DeFranco, 2014) .
IL-21 has been suggested to play an important role in T FH differentiation (Rodríguez-Bayona et al., 2012) . We showed that stimulation with CpG-DNA enhanced IL-21 production that was (predominantly IgG), but were unable to help naïve B cells (Bentebibel et al., 2013) . By activation of pDC, CpG-DNA may enhance T FH -mediated primary B cell anti-HA response induced by an inactivated virus antigen. An optimal primary response is likely to be critical for effective immunization in young children or that against a new avian influenza virus infection in humans.
CpG-DNA has a strong immunostimulatory effects on pDC (Krug et al., 2001a; Krug et al., M A N U S C R I P T
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14 | P a g e 2001b; Rothenfusser et al., 2002) and pDC has been shown to be important in anti-influenza and anti-rotavirus antibody responses upon virus infection/stimulation (Deal et al., 2013; Jego et al., 2003) . Considering that tonsillar tissue contains a prominent number of pDC (Polak et al., 2008; Rescigno, 2013) (Summers et al., 2001) , this contribution by pDC to T FH -mediated antibody response in NALT tissue may be explored in future vaccination strategy against respiratory infection.
In conclusion, abundant T FH exist in NALT of young children which suggests efficient T FH priming and it will be possible to prime T FH effectively in NALT through immunization during with CpG-DNA (0.1 µg/ml) with or without sH1N1 antigen (1 µg/ml) (*p<0.05, **p<0.01, p=10). CpG-DNA together with sH1N1 antigen elicited a marked production of anti-sH1N1 HA IgG, IgM, and IgA antibodies (d, *p<0.05, **p<0.01, n=10, aged 2-20 years). 
